23andMe Research Team

23andMe, Inc., Mountain View, CA, USA

Title	Year	PMID
A saturated map of common genetic variants associated with human height.	2022	36224396
Genetic diversity fuels gene discovery for tobacco and alcohol use.	2022	36477530
Bi-ancestral depression GWAS in the Million Veteran Program and meta-analysis in >1.2 million individuals highlight new therapeutic directions.	2021	34045744
Genome-wide association study of problematic opioid prescription use in 132,113 23andMe research participants of European ancestry.	2021	34728798
Genetic identification of cell types underlying brain complex traits yields insights into the etiology of Parkinson's disease.	2020	32341526
Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use.	2019	30643251
Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder.	2019	30478444
Genome-wide association study of alcohol use disorder identification test (AUDIT) scores in 20 328 research participants of European ancestry.	2019	29058377
Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions.	2019	30718901
A Genetic Investigation of Sex Bias in the Prevalence of Attention-Deficit/Hyperactivity Disorder.	2018	29325848
Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals.	2018	30038396
GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia.	2018	30150663
Multi-trait analysis of genome-wide association summary statistics using MTAG.	2018	29292387
Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders.	2018	30482948

23andMe Research Team

Resolved affiliation